We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu
IMPORTANT: Due to the lapse in government funding, the information on this web site may not be up to date, transactions submitted via the web site may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Face Transplantation for Treatment of Severe Facial Deformity

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01281267
Recruitment Status : Recruiting
First Posted : January 21, 2011
Last Update Posted : March 22, 2017
Sponsor:
Collaborator:
Information provided by (Responsible Party):

Study Description
Brief Summary:
Face transplantation surgery is the transfer of face tissue from a deceased human donor to a patient with a severe facial deformity. Face transplantation is an innovative reconstructive procedure that has the potential to significantly improve the lives of patients with severe facial injuries. The purpose of this study is to develop the best practices for facial transplantation that will improve the outcomes of future face transplant recipients.

Condition or disease Intervention/treatment
Severe Facial Deformity Procedure: Facial Allograft Transplantation

  Show Detailed Description

Study Design

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 10 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Transplantation of Allograft Face or Facial Subunit for Treatment of Severe Facial Deformation
Study Start Date : September 2009
Estimated Primary Completion Date : December 2017
Estimated Study Completion Date : December 2017
Arms and Interventions

Arm Intervention/treatment
Experimental: Face transplantation Procedure: Facial Allograft Transplantation
Facial allograft transplantation surgery is the transfer of face tissue from a deceased human donor to a patient with a severe facial deformity.
Other Names:
  • face transplantation
  • facial transplantation
  • composite facial allograft transplantation


Outcome Measures

Primary Outcome Measures :
  1. Outcomes of face transplantation. [ Time Frame: Subjects will be followed for 18 months after face transplantation ]
    We will undertake an objective evaluation of the results of face transplantation in an 'outcome-oriented study'.


Secondary Outcome Measures :
  1. Efficacy and optimization of the immune suppression protocol. [ Time Frame: 18 months ]
    We will evaluate the risks of rejection or likelihood of tolerance induction by measuring specific parameters in the blood or tissue, including: Serum alloantibodies concentration, numbers/phenotype of specific T cell alloreactivity in the peripheral blood, phenotypic characterization of graft infiltrating cells and local gene expression of cells and cytokines.

  2. Procedural outcomes of face transplantation [ Time Frame: From subject recruitment to 18 months after transplantation ]
    We will optimize the screening, pre-operative, peri-operative and follow-up procedures of face transplantation.

  3. Functional outcomes of face transplantation [ Time Frame: Subjects will be followed for 18 months following face transplantation ]
    We will evaluate the return of facial sensory and motor function after face transplantation.

  4. Psychosocial outcomes of face transplantation [ Time Frame: Subjects will be followed up for 18 months following face transplantation ]
    We will evaluate the psychological and social outcomes of face transplantation by evaluating the subject's quality of life at various time points before and after transplantation.

  5. Financial and economic aspects of face transplantation [ Time Frame: Subjects will be followed for 18 months after face transplantation ]
    We will evaluate the cost-effectiveness of face transplantation.


Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 60 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Age between 18 and 60 years.
  • Loss of a major part of the face, such as the nose or the lips, or at least 25% of the facial tissue.
  • The facial defect cannot be restored with traditional reconstruction techniques.
  • Signed written informed consent.
  • Willing to complete psychological and social evaluations.
  • Willing to take immunosuppressants - drugs that help prevent rejection of the transplant - for life.
  • Willing to return for follow-up visits as determined by the treating physician and to comply with extensive post-transplant rehabilitation therapy.
  • Willing to receive standard vaccinations prior to the transplant, such as influenza and hepatitis B.

Exclusion Criteria:

  • Active malignancy.
  • High risk of return of malignancy.
  • History of persistent non-compliance.
  • Findings of psychological evaluation that indicate inability to comply with physician's orders or mental instability.
  • Any diagnosis that puts the subject at risk during the face transplant surgery.
  • Absence of adequate donor sites for skin grafting in the event of transplant failure.
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01281267


Locations
United States, Massachusetts
Brigham and Women's Hospital Recruiting
Boston, Massachusetts, United States, 02115
Contact: Lisa Quinn    617-732-5303    lquinn1@partners.org   
Principal Investigator: Bohdan Pomahac, MD         
Sponsors and Collaborators
Brigham and Women's Hospital
United States Department of Defense
More Information

Additional Information:
Publications:

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Bodhan Pomahac, Medical Director, Burn Center, Brigham and Women's Hospital
ClinicalTrials.gov Identifier: NCT01281267     History of Changes
Other Study ID Numbers: 2008P000550
W911QY09C0216 ( Other Grant/Funding Number: Department of Defense )
First Posted: January 21, 2011    Key Record Dates
Last Update Posted: March 22, 2017
Last Verified: March 2017

Keywords provided by Bodhan Pomahac, Brigham and Women's Hospital:
facial transplantation
face transplantation
composite tissue allotransplantation
VCA
composite tissue allograft
facial allograft

Additional relevant MeSH terms:
Facies
Congenital Abnormalities
Disease Attributes
Pathologic Processes